期刊文献+

心力衰竭患者IL-33、IL-35的表达及临床意义 被引量:3

下载PDF
导出
摘要 目的探讨在心力衰竭(心衰)患者血清IL-33、IL-35水平的变化及意义。方法选取72例心衰患者为观察组,另选择同期门诊体检的健康人52例为对照组。统计2组血清IL-33、IL-35水平,并对心衰患者血清IL-33、IL-35水平与心衰心功能分级进行相关性分析。结果观察组血清IL-33水平明显高于对照组(P<0.05),IL-35水平明显低于对照组(P<0.05)。心衰急性期患者血清IL-33水平明显高于心衰稳定期(P<0.05),IL-35水平明显低于心衰稳定期(P<0.05)。随着心衰患者心功能分级的增加血清IL-33水平呈显著上升趋势,而血清IL-35水平呈显著下降趋势,且3组间两两比较差异均有统计学意义(P均<0.05)。扩张性心肌病患者血清IL-33、IL-35和冠心病、高血压心脏病患者比较差异均有统计学意义(P均<0.05),但冠心病组、高血压心脏病组血清IL-33、IL-35水平比较差异无统计学意义(P均>0.05)。心衰患者血清IL-33与血清IL-35水平呈明显负相关,血清IL-33与心衰患者心功能分级呈显著正相关,血清IL-35与心衰心功能分级呈显著负相关。结论 IL-33在心衰患者血清中呈现高表达,而IL-35在心衰患者血清中呈现下降趋势,IL-33、IL-35与心衰病情及严重程度密切相关。
作者 刘浩
出处 《现代中西医结合杂志》 CAS 2015年第28期3131-3133,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献15

  • 1Mc Keag NA,Mc Kinley MC,Harbinson MT,et al.The effect of multiple micronutrient supplementation on left ventricular ejection fraction in patients with chronic stable heart failure:a randomized,placebo-controlled trial[J].JACC Heart Fail,2014,2(3):308-317.
  • 2Kiss T,Kovacs K,Komocsi A,et al.Novel mechanisms of sildenafil in pulmonary hypertension involving cytokines/chemokines,MAP kinases and Akt[J].PLo S One,2014,9(8):e104890.
  • 3Yoshida T,Friehs I,Mummidi S,et al.Pressure overload induces IL-18 and IL-18R expression,but markedly suppresses IL-18BP expression in a rabbit model.IL-18 potentiates TNF-α-induced cardiomyocyte death[J].J Mol Cell Cardiol,2014,75:141-151.
  • 4董晓蕾,常文静,蔡辉.炎性细胞因子与慢性心力衰竭[J].中华老年心脑血管病杂志,2013,15(4):438-441. 被引量:55
  • 5Lam ET,Wong MK,Agarwal N,et al.Retrospective analysis of the safety and efficacy of high-dose interleukin-2 after prior tyrosine kinase inhibitor therapy in patients with advanced renal cell carcinoma[J].J Immunother,2014,37(7):360-365.
  • 6Sánchez-Más J,Lax A,Asensio-López Mdel C,et al.Modulation of IL-33/ST2 system in postinfarction heart failure:correlation with cardiac remodelling markers[J].Eur J Clin Invest,2014,44(7):643-651.
  • 7Moe KT,Khairunnisa K,Yin NO,et al.Tumor necrosis factor-α-induced nuclear factor-kappa B activation in human cardiomyocytes is mediated by NADPH oxidase[J].J Physiol Biochem,2014,70(3):769-779.
  • 8Wu L,Ong S,Talor MV,et al.Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy[J].J Exp Med,2014,211(7):1449-1464.
  • 9Bracey NA,Gershkovich B,Chun J,et al.Mitochondrial NLRP3 protein induces reactive oxygen species to promote Smad protein signaling and fibrosis independent from the inflammasome[J].J Biol Chem,2014,289(28):19571-19584.
  • 10王登峰,李昌.参麦注射液对慢性心力衰竭患者TNF-α、IL-12水平及心功能的影响[J].海南医学院学报,2013,19(1):38-40. 被引量:11

二级参考文献58

  • 1王绪玲,廖培元,丁芳,朱琳.参麦注射液对病毒性心肌炎患儿血清TNF-α、IL-6的影响及临床意义[J].中国实用医刊,2010,37(24):50-51. 被引量:1
  • 2Kalogeropoulos AP, Georgiopoulou VV,Butler J. From riskfactors to structural heart disease : the role of inflammation.Heart Fail Clin,20l2 ,8 : 113-123.
  • 3Tziakas D,Chalikias G’Parissis JT,et al. Prolonged activationof tumor necrosis factor(TNF")-alpha and its soluble receptorsin chronic heart failure patients both in the compensated anddecompensated state. Interplay between their levels and met-alloproteinase-3. Eur Cytokine Netw,2004 ,15 : 231-239.
  • 4Takayoshi T, Atsuyuki W, Matsumoto T, et al. Relationshipbetween tumor necrosis factor-alpha production and oxidativestress in the failing hearts of patients with dilated cardiomy-opathy. J Am Cardiol,2001,37 -.2086-2092.
  • 5Fernandez-Velasco M,Ruiz- Hurtado G, Hurtado O,et al.TNF-alpha downregulates transient outward potassium cur-rent in rat ventricular myocytes through iNOS overexpressionand oxidant species generation. Am J Physiol Heart CircPhysiol,2007.293:H238-H245.
  • 6Hamid T,Gu Y, Ortines RV. et al. Divergent tumor necrosisfactor receptor-related remodeling responses in heart failure:role of nuclear factor-kappaB and inflammatory activation.Circulation, 2009,119:1386-1397.
  • 7Niessner A,Hohensinner PJ,Rychli K,et al. Prognostic valueof apoptosis markers in advanced heart failure patients. EurHeart J,2009,30:789-796.
  • 8Seko Y.Ishiyama S,Nishikawa T,et al. Expression of tumornecrosis factor ligand superfamily costimulatory moleculesCD27L, CD30L, OX40L and 4-1BBL in the heart of patientswith acute myocarditis and dilated cardiomyopathy. Cardio-vasc Pathol, 2002.11 : 166-170.
  • 9Ueland T, Aukrust P, Yndestad A’et al. Soluble CD40 ligandin acute and chronic heart failure. Eur Heart J ,2005,26 s 1101-1107.
  • 10Raymond RJ,Dehmer GJ*Theoharides TC’et al. Elevated in-terleukin-6 levels in patients with asymptomatic left ventricu-lar systolic dysfunction. Am Heart J,2001 ’ 141:435-438.

共引文献73

同被引文献9

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部